BioArctic AB (publ) BIOA-B.ST Stock
BioArctic AB (publ) Price Chart
BioArctic AB (publ) BIOA-B.ST Financial and Trading Overview
| BioArctic AB (publ) stock price | 230.2 SEK |
| Previous Close | 334 SEK |
| Open | 333.8 SEK |
| Bid | 342.8 SEK x N/A |
| Ask | 343.6 SEK x N/A |
| Day's Range | 331 - 343.6 SEK |
| 52 Week Range | 69.3 - 392 SEK |
| Volume | 55.48K SEK |
| Avg. Volume | 190.51K SEK |
| Market Cap | 30.31B SEK |
| Beta (5Y Monthly) | 0.434482 |
| PE Ratio (TTM) | 101.05882 |
| EPS (TTM) | 2.6 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 10, 2019 |
| 1y Target Est | 396 SEK |
BIOA-B.ST Valuation Measures
| Enterprise Value | 29.52B SEK |
| Trailing P/E | 101.05882 |
| Forward P/E | 51.207153 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 48.737495 |
| Price/Book (mrq) | 27.914534 |
| Enterprise Value/Revenue | 47.457 |
| Enterprise Value/EBITDA | 85.276 |
Trading Information
BioArctic AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.434482 |
| 52-Week Change | 361.96% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 392 SEK |
| 52 Week Low | 69.3 SEK |
| 50-Day Moving Average | 286.54 SEK |
| 200-Day Moving Average | 263.82 SEK |
BIOA-B.ST Share Statistics
| Avg. Volume (3 month) | 190.51K SEK |
| Avg. Daily Volume (10-Days) | 323.92K SEK |
| Shares Outstanding | 73.83M |
| Float | 37.17M |
| Short Ratio | N/A |
| % Held by Insiders | 47.15% |
| % Held by Institutions | 31.50% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 52.56% |
| Operating Margin (ttm) | 54.50% |
| Gross Margin | 85.60% |
| EBITDA Margin | 55.65% |
Management Effectiveness
| Return on Assets (ttm) | 21.17% |
| Return on Equity (ttm) | 35.72% |
Income Statement
| Revenue (ttm) | 622M SEK |
| Revenue Per Share (ttm) | 7.06 SEK |
| Quarterly Revenue Growth (yoy) | 9439.00% |
| Gross Profit (ttm) | 155.54M SEK |
| EBITDA | 346.15M SEK |
| Net Income Avi to Common (ttm) | 326.93M SEK |
| Diluted EPS (ttm) | 3.4 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.11B SEK |
| Total Cash Per Share (mrq) | 12.54 SEK |
| Total Debt (mrq) | 7.92M SEK |
| Total Debt/Equity (mrq) | 0.73 SEK |
| Current Ratio (mrq) | 16.283 |
| Book Value Per Share (mrq) | 12.309 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 307.04M SEK |
| Levered Free Cash Flow (ttm) | 181.91M SEK |
Profile of BioArctic AB (publ)
| Country | Sweden |
| State | N/A |
| City | Stockholm |
| Address | Warfvinges vag 35 |
| ZIP | 112 51 |
| Phone | 46 86 95 69 30 |
| Website | https://www.bioarctic.se |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 69 |
BioArctic AB (publ) develops biological drugs for patients with neurodegenerative disorders in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. It also develops ABBV-0805, for treating Parkinson's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain, as well as focuses on developing ND3014 antibodies for treating neurodegenerative disorders. Further, it develops BAN1503, AD-BT2802, AD-BT2803, AD1502, AD1503, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814 andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, BAN0805, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.
Q&A For BioArctic AB (publ) Stock
What is a current BIOA-B.ST stock price?
BioArctic AB (publ) BIOA-B.ST stock price today per share is 230.2 SEK.
How to purchase BioArctic AB (publ) stock?
You can buy BIOA-B.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioArctic AB (publ)?
The stock symbol or ticker of BioArctic AB (publ) is BIOA-B.ST.
Which industry does the BioArctic AB (publ) company belong to?
The BioArctic AB (publ) industry is Biotechnology.
How many shares does BioArctic AB (publ) have in circulation?
The max supply of BioArctic AB (publ) shares is 88.32M.
What is BioArctic AB (publ) Price to Earnings Ratio (PE Ratio)?
BioArctic AB (publ) PE Ratio is 88.53847000 now.
What was BioArctic AB (publ) earnings per share over the trailing 12 months (TTM)?
BioArctic AB (publ) EPS is 2.6 SEK over the trailing 12 months.
Which sector does the BioArctic AB (publ) company belong to?
The BioArctic AB (publ) sector is Healthcare.
BioArctic AB (publ) BIOA-B.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX Stockholm_GI OMXSGI | 491.98 SEK 48.02 USD |
-0.21
|
— — | 489.97 SEK 47.83 USD | 492.23 SEK 48.05 USD | — - | — — |
| OMX Stockholm Benchmark_PI OMXSBPI | 834.53 SEK 81.46 USD |
-0.24
|
— — | 830.96 SEK 81.11 USD | 835.41 SEK 81.55 USD | — - | — — |
| OMX Stockholm Benchmark_GI OMXSBGI | 1978.63 SEK 193.14 USD |
-0.23
|
— — | 1970.16 SEK 192.31 USD | 1980.71 SEK 193.34 USD | — - | — — |
| OMX Stockholm Benchmark Cap_GI OMXSBCAPGI | 2307.61 SEK 225.25 USD |
-0.23
|
— — | 2297.77 SEK 224.29 USD | 2310 SEK 225.48 USD | — - | — — |
| OMX_Nordic_Large_Cap_ISK_GI OMXNLCISKGI | 641.22 ISK 4.71 USD |
-0.49
|
— — | 639.8 ISK 4.7 USD | 643.96 ISK 4.74 USD | — - | — — |
| OMX Stockholm Health Care PI SX20PI | 3555.26 SEK 347.04 USD |
-0.03
|
— — | 3517.52 SEK 343.35 USD | 3546.31 SEK 346.16 USD | — - | — — |
| OMX_Nordic_Large_Cap_DKK_GI OMXNLCDKKGI | 443.98 DKK 65.1 USD |
-0.48
|
— — | 442.95 DKK 64.95 USD | 445.8 DKK 65.36 USD | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030PI | 5594.79 SEK 546.12 USD |
-0.47
|
— — | 5594.79 SEK 546.12 USD | 5594.79 SEK 546.12 USD | — - | — — |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| OMX Stockholm_PI OMXSPI | 990.72 SEK 96.71 USD |
-0.23
|
— — | 986.67 SEK 96.31 USD | 991.23 SEK 96.76 USD | — - | — — |
| NASDAQ OMX Small Cap Sweden GI NOMXSCSEGI | 4437.69 SEK 433.17 USD |
+0.08
|
— — | 4421.86 SEK 431.63 USD | 4441.05 SEK 433.5 USD | — - | — — |
| OMX_Stockholm_Large_Cap_GI OMXSLCGI | 517.11 SEK 50.48 USD |
-0.24
|
— — | 515.03 SEK 50.27 USD | 517.45 SEK 50.51 USD | — - | — — |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 481.88 SEK 47.04 USD |
-0.21
|
— — | 479.9 SEK 46.84 USD | 482.12 SEK 47.06 USD | — - | — — |
| OMX Stockholm Benchmark_GI Exp OMXSBGIEXP | 1977.26 SEK 193 USD |
-0.36
|
— — | 1974.12 SEK 192.7 USD | 1979.01 SEK 193.18 USD | — - | — — |
| OMX Stockholm Benchmark Cap_PI OMXSBCAPPI | 957.46 SEK 93.46 USD |
-0.24
|
— — | 953.38 SEK 93.06 USD | 958.45 SEK 93.56 USD | — - | — — |
- {{ link.label }} {{link}}